BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 33165928)

  • 21. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
    Cheng F; Su L; Qian C
    Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Cancer Therapy: Liquid Biopsy.
    Marmé D
    Oncol Res Treat; 2017; 40(7-8):402-403. PubMed ID: 28728143
    [No Abstract]   [Full Text] [Related]  

  • 23. [Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers].
    Perrier A; Hainaut P; Guenoun A; Nguyen DP; Lamy PJ; Guerber F; Troalen F; Denis JA; Boissan M
    Bull Cancer; 2022 Feb; 109(2):170-184. PubMed ID: 35034786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translational Application of Circulating DNA in Oncology: Review of the Last Decades Achievements.
    Tuaeva NO; Falzone L; Porozov YB; Nosyrev AE; Trukhan VM; Kovatsi L; Spandidos DA; Drakoulis N; Kalogeraki A; Mamoulakis C; Tzanakakis G; Libra M; Tsatsakis A
    Cells; 2019 Oct; 8(10):. PubMed ID: 31615102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detection.
    Fiala C; Diamandis EP
    Clin Chem Lab Med; 2020 Sep; 58(10):1651-1653. PubMed ID: 32160156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward liquid biopsies in cancer treatment: application of circulating tumor DNA.
    Barlebo Ahlborn L; Østrup O
    APMIS; 2019 May; 127(5):329-336. PubMed ID: 30784124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tumor DNA and liquid biopsy in oncology.
    Cescon DW; Bratman SV; Chan SM; Siu LL
    Nat Cancer; 2020 Mar; 1(3):276-290. PubMed ID: 35122035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating Tumor DNA: A Step into the Future of Cancer Management.
    Fernandes Marques J; Pereira Reis J; Fernandes G; Hespanhol V; Machado JC; Costa JL
    Acta Cytol; 2019; 63(6):456-465. PubMed ID: 30852572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A New Horizon in Cancer Care: Liquid Biopsy.
    Copur M
    Oncology (Williston Park); 2021 Dec; 35(12):798-799. PubMed ID: 35089002
    [No Abstract]   [Full Text] [Related]  

  • 30. Circulating Tumor DNA Assays in Clinical Cancer Research.
    Ossandon MR; Agrawal L; Bernhard EJ; Conley BA; Dey SM; Divi RL; Guan P; Lively TG; McKee TC; Sorg BS; Tricoli JV
    J Natl Cancer Inst; 2018 Sep; 110(9):929-934. PubMed ID: 29931312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liquid Biopsy: Current Status and Future Perspectives.
    Mader S; Pantel K
    Oncol Res Treat; 2017; 40(7-8):404-408. PubMed ID: 28693023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Circulating Tumor DNA Testing for Precision Oncology.
    Kim H; Park KU
    Cancer Res Treat; 2023 Apr; 55(2):351-366. PubMed ID: 36915242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent Advances in Liquid Biopsy in Precision Oncology Research.
    Sato Y; Matoba R; Kato K
    Biol Pharm Bull; 2019; 42(3):337-342. PubMed ID: 30828064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of circulating tumor DNA in pediatric solid tumors: The promise of liquid biopsies.
    Abbou SD; Shulman DS; DuBois SG; Crompton BD
    Pediatr Blood Cancer; 2019 May; 66(5):e27595. PubMed ID: 30614191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.
    Salati M; Venetis K; Fassan M; Malapelle U; Pagni F; Sajjadi E; Fusco N; Ghidini M
    Future Oncol; 2021 Nov; 17(33):4607-4618. PubMed ID: 34406032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of liquid biopsies in colorectal cancer.
    Wills B; Gorse E; Lee V
    Curr Probl Cancer; 2018 Nov; 42(6):593-600. PubMed ID: 30268335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single tube liquid biopsy for advanced non-small cell lung cancer.
    de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
    Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumour DNA for clinicians: current and future clinical applications.
    Thompson MK; Gale D; Brenton JD
    Clin Radiol; 2021 Oct; 76(10):737-747. PubMed ID: 34389159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies.
    Valpione S; Campana L
    Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
    Merker JD; Oxnard GR; Compton C; Diehn M; Hurley P; Lazar AJ; Lindeman N; Lockwood CM; Rai AJ; Schilsky RL; Tsimberidou AM; Vasalos P; Billman BL; Oliver TK; Bruinooge SS; Hayes DF; Turner NC
    J Clin Oncol; 2018 Jun; 36(16):1631-1641. PubMed ID: 29504847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.